651 related articles for article (PubMed ID: 11859097)
1. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells.
Engering A; Geijtenbeek TB; van Vliet SJ; Wijers M; van Liempt E; Demaurex N; Lanzavecchia A; Fransen J; Figdor CG; Piguet V; van Kooyk Y
J Immunol; 2002 Mar; 168(5):2118-26. PubMed ID: 11859097
[TBL] [Abstract][Full Text] [Related]
2. Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses.
Dakappagari N; Maruyama T; Renshaw M; Tacken P; Figdor C; Torensma R; Wild MA; Wu D; Bowdish K; Kretz-Rommel A
J Immunol; 2006 Jan; 176(1):426-40. PubMed ID: 16365436
[TBL] [Abstract][Full Text] [Related]
3. Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants.
Berzi A; Ordanini S; Joosten B; Trabattoni D; Cambi A; Bernardi A; Clerici M
Sci Rep; 2016 Oct; 6():35373. PubMed ID: 27734954
[TBL] [Abstract][Full Text] [Related]
4. DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission.
Geijtenbeek TB; van Kooyk Y
Curr Top Microbiol Immunol; 2003; 276():31-54. PubMed ID: 12797442
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.
Ludwig IS; Lekkerkerker AN; Depla E; Bosman F; Musters RJ; Depraetere S; van Kooyk Y; Geijtenbeek TB
J Virol; 2004 Aug; 78(15):8322-32. PubMed ID: 15254204
[TBL] [Abstract][Full Text] [Related]
6. The C-type lectin DC-SIGN internalizes soluble antigens and HIV-1 virions via a clathrin-dependent mechanism.
Cambi A; Beeren I; Joosten B; Fransen JA; Figdor CG
Eur J Immunol; 2009 Jul; 39(7):1923-8. PubMed ID: 19585517
[TBL] [Abstract][Full Text] [Related]
7. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection.
Bashirova AA; Geijtenbeek TB; van Duijnhoven GC; van Vliet SJ; Eilering JB; Martin MP; Wu L; Martin TD; Viebig N; Knolle PA; KewalRamani VN; van Kooyk Y; Carrington M
J Exp Med; 2001 Mar; 193(6):671-8. PubMed ID: 11257134
[TBL] [Abstract][Full Text] [Related]
8. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
9. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
[TBL] [Abstract][Full Text] [Related]
10. Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts.
Mummidi S; Catano G; Lam L; Hoefle A; Telles V; Begum K; Jimenez F; Ahuja SS; Ahuja SK
J Biol Chem; 2001 Aug; 276(35):33196-212. PubMed ID: 11337487
[TBL] [Abstract][Full Text] [Related]
11. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
[TBL] [Abstract][Full Text] [Related]
12. Mycobacteria target DC-SIGN to suppress dendritic cell function.
Geijtenbeek TB; Van Vliet SJ; Koppel EA; Sanchez-Hernandez M; Vandenbroucke-Grauls CM; Appelmelk B; Van Kooyk Y
J Exp Med; 2003 Jan; 197(1):7-17. PubMed ID: 12515809
[TBL] [Abstract][Full Text] [Related]
13. Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity.
Schetters STT; Kruijssen LJW; Crommentuijn MHW; Kalay H; Ochando J; den Haan JMM; Garcia-Vallejo JJ; van Kooyk Y
Front Immunol; 2018; 9():990. PubMed ID: 29867967
[TBL] [Abstract][Full Text] [Related]
14. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
[TBL] [Abstract][Full Text] [Related]
15. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.
Horrevorts SK; Duinkerken S; Bloem K; Secades P; Kalay H; Musters RJ; van Vliet SJ; García-Vallejo JJ; van Kooyk Y
Front Immunol; 2018; 9():1231. PubMed ID: 29963041
[TBL] [Abstract][Full Text] [Related]
17. Oligolysine-based oligosaccharide clusters: selective recognition and endocytosis by the mannose receptor and dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin.
Frison N; Taylor ME; Soilleux E; Bousser MT; Mayer R; Monsigny M; Drickamer K; Roche AC
J Biol Chem; 2003 Jun; 278(26):23922-9. PubMed ID: 12695508
[TBL] [Abstract][Full Text] [Related]
18. DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes.
de Witte L; de Vries RD; van der Vlist M; Yüksel S; Litjens M; de Swart RL; Geijtenbeek TB
PLoS Pathog; 2008 Apr; 4(4):e1000049. PubMed ID: 18421379
[TBL] [Abstract][Full Text] [Related]
19. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
Soilleux EJ
Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
[TBL] [Abstract][Full Text] [Related]
20. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.
Geijtenbeek TB; Torensma R; van Vliet SJ; van Duijnhoven GC; Adema GJ; van Kooyk Y; Figdor CG
Cell; 2000 Mar; 100(5):575-85. PubMed ID: 10721994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
